IN8bio Inc (INAB)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.20+3.45%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · INAB
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| R&D Expenses | 9.9 | 10.2 | 17.0 | 16.8 | 14.1 | 7.3 | 5.4 |
| Operating Income | (18.7) | (19.4) | (30.4) | (30.0) | (28.5) | (14.7) | (8.6) |
| Earnings from Continuing Operations | |||||||
| Interest & Investment Income | 0.5 | 0.4 | 0.2 | 0.0 | — | — | — |
| EBT, Incl. Unusual Items | — | (19.4) | — | — | — | — | — |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | (18.7) | (19.4) | (30.4) | (30.0) | (28.5) | (14.7) | (8.6) |
| Per Share | |||||||
| Basic EPS | (0.96) | (4.44) | (0.57) | (1.00) | (1.36) | (1.47) | — |
| Diluted EPS | (0.96) | (4.44) | (0.57) | (1.00) | (1.36) | (1.47) | — |
| Basic Weighted Avg Shares | 19.5 | 4.4 | 53.5 | 29.9 | 21.0 | 10.0 | — |
| Diluted Weighted Avg Shares | 19.5 | 4.4 | 53.5 | 29.9 | 21.0 | 10.0 | — |
| Supplemental | |||||||
| EBIT | (18.7) | (19.4) | (30.4) | (30.0) | (28.5) | (14.7) | (8.6) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.